CREATE Medicines has successfully raised $122 million in a Series B financing round led by Newpath Partners and ARCH Venture Partners to advance its CAR-T therapy pipeline.
Amount Raised
$122 Million
Round Type
Series B
CambridgeBiotechnologyHealth CareTherapeuticsInvestors
Description
CREATE Medicines, Inc. has announced the closure of its $122 million Series B funding round, co-led by Newpath Partners and ARCH Venture Partners. The funding will be used to support the advancement of its CAR-T therapy for autoimmune diseases and oncology. CREATE has already dosed over 50 patients in its clinical programs
Quick answer
CREATE Medicines raised $122 Million in a Series B round, dated May 14, 2026. Investors: Hatteras Venture Partners, Alexandria Venture Investments, Newpath Partners and ARCH Venture Partners. CREATE Medicines is based in Cambridge, Massachusetts, United States.
- How much did CREATE Medicines raise?
- CREATE Medicines raised $122 Million in a Series B round on May 14, 2026.
- Who invested in CREATE Medicines?
- Hatteras Venture Partners, Alexandria Venture Investments, Newpath Partners and ARCH Venture Partners are named as investors in this round.
- What does CREATE Medicines do?
- CREATE Medicines is a clinical-stage biotech pioneering in vivo multi-immune programming.
- Where is CREATE Medicines based and how big is it?
- CREATE Medicines is based in Cambridge, Massachusetts, United States. Fundz records about 42 employees.
- Who are the decision-makers at CREATE Medicines?
- Fundz holds 1 contact at CREATE Medicines. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as CREATE Medicines that raised within 45 days of this round, from Fundz verified event records.
- Thalia Therapeutics plc raised $3.5M (Seed) on June 26, 2026.
- FibroBiologics raised $3M (Post-IPO Equity) on June 25, 2026.
- Serapha Bio raised $230M (Series A) on June 25, 2026.
- Imagion Biosystems raised $2.8M (Post-IPO Equity) on June 25, 2026.
- Oblenio Bio raised $62M (Series B) on June 25, 2026.
- Osanni Bio raised $190M (Series B) on June 23, 2026.
Who to call at CREATE Medicines, and when
A new round usually means CREATE Medicines is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day CREATE Medicines raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CREATE Medicines, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CREATE Medicines. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CREATE Medicines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCREATE Medicines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.